 | • レポートコード：QFJ1-4690 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、個別化がんワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、白血病、前立腺がん、子宮頸がん、神経膠芽細胞腫、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・個別化がんワクチンの市場動向 ・企業の競争状況、市場シェア ・個別化がんワクチンの種類別市場規模と予測2016-2027（肺がん、乳がん、結腸直腸がん、白血病、前立腺がん、子宮頸がん、神経膠芽細胞腫、その他） ・個別化がんワクチンの用途別市場規模と予測2016-2027（病院、在宅医療、専門クリニック、その他） ・個別化がんワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・個別化がんワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・個別化がんワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・個別化がんワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・個別化がんワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Advaxis Inc、Personalis、Hoffmann-La Roche Ltd、BioNtech、Celldex、CureVac AG、Genetech、Genocea、Gritstone Oncology、ISA Pharmaceuticals、Merck、Moderna Therapeutics） ・結論 |
Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.
Market Analysis and Insights: Global Personalized Cancer Vaccines Market
The global Personalized Cancer Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cancer Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cancer Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cancer Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cancer Vaccines market.
Global Personalized Cancer Vaccines Scope and Market Size
Personalized Cancer Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Others
By Mechanism of Action Type
Tumor-associated antigens (TAAs)
Tumor-specific antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Leukemia
1.2.6 Prostate Cancer
1.2.7 Cervical Cancer
1.2.8 Glioblastoma
1.2.9 Others
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2016-2027)
2.2 Personalized Cancer Vaccines Growth Trends by Regions
2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Cancer Vaccines Industry Dynamic
2.3.1 Personalized Cancer Vaccines Market Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2016-2021)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2020
3.5 Personalized Cancer Vaccines Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
3.7 Date of Enter into Personalized Cancer Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027)
5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2016-2027)
6.2 North America Personalized Cancer Vaccines Market Size by Type
6.2.1 North America Personalized Cancer Vaccines Market Size by Type (2016-2021)
6.2.2 North America Personalized Cancer Vaccines Market Size by Type (2022-2027)
6.2.3 North America Personalized Cancer Vaccines Market Size by Type (2016-2027)
6.3 North America Personalized Cancer Vaccines Market Size by Application
6.3.1 North America Personalized Cancer Vaccines Market Size by Application (2016-2021)
6.3.2 North America Personalized Cancer Vaccines Market Size by Application (2022-2027)
6.3.3 North America Personalized Cancer Vaccines Market Size by Application (2016-2027)
6.4 North America Personalized Cancer Vaccines Market Size by Country
6.4.1 North America Personalized Cancer Vaccines Market Size by Country (2016-2021)
6.4.2 North America Personalized Cancer Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2016-2027)
7.2 Europe Personalized Cancer Vaccines Market Size by Type
7.2.1 Europe Personalized Cancer Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Personalized Cancer Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Personalized Cancer Vaccines Market Size by Type (2016-2027)
7.3 Europe Personalized Cancer Vaccines Market Size by Application
7.3.1 Europe Personalized Cancer Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Personalized Cancer Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Personalized Cancer Vaccines Market Size by Application (2016-2027)
7.4 Europe Personalized Cancer Vaccines Market Size by Country
7.4.1 Europe Personalized Cancer Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Personalized Cancer Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type
8.2.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application
8.3.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region
8.4.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2016-2027)
9.2 Latin America Personalized Cancer Vaccines Market Size by Type
9.2.1 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2027)
9.3 Latin America Personalized Cancer Vaccines Market Size by Application
9.3.1 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2027)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country
9.4.1 Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type
10.2.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application
10.3.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country
10.4.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Details
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Details
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Details
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Details
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Details
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Details
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Details
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Details
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Details
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Details
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Details
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.12.5 Moderna Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Personalized Cancer Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lung Cancer
Table 3. Key Players of Breast Cancer
Table 4. Key Players of Colorectal Cancer
Table 5. Key Players of Leukemia
Table 6. Key Players of Prostate Cancer
Table 7. Key Players of Cervical Cancer
Table 8. Key Players of Glioblastoma
Table 9. Key Players of Others
Table 10. Global Personalized Cancer Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Personalized Cancer Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Personalized Cancer Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Personalized Cancer Vaccines Market Share by Regions (2016-2021)
Table 14. Global Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Personalized Cancer Vaccines Market Share by Regions (2022-2027)
Table 16. Personalized Cancer Vaccines Market Trends
Table 17. Personalized Cancer Vaccines Market Drivers
Table 18. Personalized Cancer Vaccines Market Challenges
Table 19. Personalized Cancer Vaccines Market Restraints
Table 20. Global Personalized Cancer Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Personalized Cancer Vaccines Market Share by Players (2016-2021)
Table 22. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Vaccines as of 2020)
Table 23. Ranking of Global Top Personalized Cancer Vaccines Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Personalized Cancer Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Personalized Cancer Vaccines Product Solution and Service
Table 27. Date of Enter into Personalized Cancer Vaccines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Personalized Cancer Vaccines Revenue Market Share by Type (2016-2021)
Table 31. Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Personalized Cancer Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Personalized Cancer Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Personalized Cancer Vaccines Revenue Market Share by Application (2016-2021)
Table 35. Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Personalized Cancer Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 67. Advaxis Inc Company Details
Table 68. Advaxis Inc Business Overview
Table 69. Advaxis Inc Personalized Cancer Vaccines Product
Table 70. Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 71. Advaxis Inc Recent Development
Table 72. Personalis Company Details
Table 73. Personalis Business Overview
Table 74. Personalis Personalized Cancer Vaccines Product
Table 75. Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 76. Personalis Recent Development
Table 77. Hoffmann-La Roche Ltd Company Details
Table 78. Hoffmann-La Roche Ltd Business Overview
Table 79. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product
Table 80. Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 81. Hoffmann-La Roche Ltd Recent Development
Table 82. BioNtech Company Details
Table 83. BioNtech Business Overview
Table 84. BioNtech Personalized Cancer Vaccines Product
Table 85. BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 86. BioNtech Recent Development
Table 87. Celldex Company Details
Table 88. Celldex Business Overview
Table 89. Celldex Personalized Cancer Vaccines Product
Table 90. Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 91. Celldex Recent Development
Table 92. CureVac AG Company Details
Table 93. CureVac AG Business Overview
Table 94. CureVac AG Personalized Cancer Vaccines Product
Table 95. CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 96. CureVac AG Recent Development
Table 97. Genetech Company Details
Table 98. Genetech Business Overview
Table 99. Genetech Personalized Cancer Vaccines Product
Table 100. Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 101. Genetech Recent Development
Table 102. Genocea Company Details
Table 103. Genocea Business Overview
Table 104. Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 105. Genocea Recent Development
Table 106. Gritstone Oncology Company Details
Table 107. Gritstone Oncology Business Overview
Table 108. Gritstone Oncology Personalized Cancer Vaccines Product
Table 109. Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 110. Gritstone Oncology Recent Development
Table 111. ISA Pharmaceuticals Company Details
Table 112. ISA Pharmaceuticals Business Overview
Table 113. ISA Pharmaceuticals Personalized Cancer Vaccines Product
Table 114. ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 115. ISA Pharmaceuticals Recent Development
Table 116. Merck Company Details
Table 117. Merck Business Overview
Table 118. Merck Personalized Cancer Vaccines Product
Table 119. Merck Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 120. Merck Recent Development
Table 121. Moderna Therapeutics Company Details
Table 122. Moderna Therapeutics Business Overview
Table 123. Moderna Therapeutics Personalized Cancer Vaccines Product
Table 124. Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million)
Table 125. Moderna Therapeutics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Lung Cancer Features
Figure 3. Breast Cancer Features
Figure 4. Colorectal Cancer Features
Figure 5. Leukemia Features
Figure 6. Prostate Cancer Features
Figure 7. Cervical Cancer Features
Figure 8. Glioblastoma Features
Figure 9. Others Features
Figure 10. Global Personalized Cancer Vaccines Market Share by Application: 2020 VS 2027
Figure 11. Hospitals Case Studies
Figure 12. Homecare Case Studies
Figure 13. Specialty Clinics Case Studies
Figure 14. Others Case Studies
Figure 15. Personalized Cancer Vaccines Report Years Considered
Figure 16. Global Personalized Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Personalized Cancer Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Personalized Cancer Vaccines Market Share by Regions: 2020 VS 2027
Figure 19. Global Personalized Cancer Vaccines Market Share by Regions (2022-2027)
Figure 20. Global Personalized Cancer Vaccines Market Share by Players in 2020
Figure 21. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Vaccines as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2020
Figure 23. Global Personalized Cancer Vaccines Revenue Market Share by Type (2016-2021)
Figure 24. Global Personalized Cancer Vaccines Revenue Market Share by Type (2022-2027)
Figure 25. North America Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Personalized Cancer Vaccines Market Share by Type (2016-2027)
Figure 27. North America Personalized Cancer Vaccines Market Share by Application (2016-2027)
Figure 28. North America Personalized Cancer Vaccines Market Share by Country (2016-2027)
Figure 29. United States Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Personalized Cancer Vaccines Market Share by Type (2016-2027)
Figure 33. Europe Personalized Cancer Vaccines Market Share by Application (2016-2027)
Figure 34. Europe Personalized Cancer Vaccines Market Share by Country (2016-2027)
Figure 35. Germany Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Personalized Cancer Vaccines Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Personalized Cancer Vaccines Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Personalized Cancer Vaccines Market Share by Region (2016-2027)
Figure 45. China Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Personalized Cancer Vaccines Market Share by Type (2016-2027)
Figure 53. Latin America Personalized Cancer Vaccines Market Share by Application (2016-2027)
Figure 54. Latin America Personalized Cancer Vaccines Market Share by Country (2016-2027)
Figure 55. Mexico Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Personalized Cancer Vaccines Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Personalized Cancer Vaccines Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Personalized Cancer Vaccines Market Share by Country (2016-2027)
Figure 61. Turkey Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Advaxis Inc Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 65. Personalis Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 66. Hoffmann-La Roche Ltd Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 67. BioNtech Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 68. Celldex Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 69. CureVac AG Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 70. Genetech Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 71. Genocea Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 72. Gritstone Oncology Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 73. ISA Pharmaceuticals Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 75. Moderna Therapeutics Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の個別化がん医療市場規模・現状・予測（2021年-2027年） Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors c…- 世界の乳がん診断市場規模・現状・予測（2021年-2027年） Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI and biopsy. Market Analysis and Insights: Global Breast Cancer Diagnostic Market The global Breast Cancer Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の前立腺がん市場規模・現状・予測（2021年-2027年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in a…
- 世界の結腸直腸癌診断市場規模・現状・予測（2021年-2027年） Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecul…
- 世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…